Luminex Corp (LMNX):企業の財務・戦略的SWOT分析

◆英語タイトル:Luminex Corp (LMNX) - Financial and Strategic SWOT Analysis Review
◆商品コード:SWOT20MY1586
◆発行会社(調査会社):GlobalData
◆発行日:2020年4月
◆ページ数:57
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:Medical Devices
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD125 ⇒換算¥13,500見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD250 ⇒換算¥27,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD375 ⇒換算¥40,500見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Luminex Corp (LMNX) – Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Luminex Corp (Luminex) develops, manufactures and markets proprietary biological testing technologies. The company offers wide range of products including instruments, assays, reagents and accessories, software and replacement parts. It employs its proprietary technologies to test for proteins and nucleic acids, and to serve multiplexing, precision, sensitivity, accuracy, and for reduction of labor. Luminex offers its products to various markets such as clinical diagnostics; pharmaceutical drug discovery; biomedical research including personalized medicine, genomic and proteomic research, biodefense research and food safety. The company sells its products through direct sales channel and strategic distribution partners in Asia-Pacific North America and Europe. Luminex is headquartered in Texas, the US.

Luminex Corp Key Recent Developments

Apr 06,2020 Luminex Pre-Release of 1st Quarter Revenue
Mar 04,2020 Luminex provides updates on critical efforts related to novel coronavirus

Feb 10,2020 Luminex reports fourth quarter and full-year 2019 results
Jan 12,2020 Luminex Corporation announces 2019 highlights and 2020 guidance; company to present at 38th annual J.P. Morgan Healthcare conference

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
Table of Contents
List of Tables
List of Figures
Section 1 – About the Company
Luminex Corp – Key Facts
Luminex Corp – Key Employees
Luminex Corp – Key Employee Biographies
Luminex Corp – Major Products and Services
Luminex Corp – History
Luminex Corp – Company Statement
Luminex Corp – Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Section 2 – Company Analysis
Company Overview
Luminex Corp – Business Description
Business Segment: Assay
Overview
Performance
Business Segment: Consumables
Overview
Performance
Business Segment: Other
Overview
Performance
Business Segment: Royalty
Overview
Performance
Business Segment: Service
Overview
Performance
Business Segment: System
Overview
Performance
Geographical Segment: Asia
Performance
Geographical Segment: Canada
Performance
Geographical Segment: Domestic
Performance
Geographical Segment: Europe
Performance
Geographical Segment: Other Regions
Performance
R&D Overview
Luminex Corp – Corporate Strategy
Luminex Corp – SWOT Analysis
SWOT Analysis – Overview
Luminex Corp – Strengths
Luminex Corp – Weaknesses
Luminex Corp – Opportunities
Luminex Corp – Threats
Luminex Corp – Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Performance Chart
Financial Performance
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts
Section 4 – Company’s Lifesciences Financial Deals and Alliances
Luminex Corp, Medical Equipment, Deals By Year, 2014 to YTD 2020
Luminex Corp, Medical Equipment, Deals By Type, 2014 to YTD 2020
Luminex Corp, Recent Deals Summary
Section 5 – Company’s Recent Developments
Apr 06, 2020: Luminex Pre-Release of 1st Quarter Revenue
Mar 04, 2020: Luminex provides updates on critical efforts related to novel coronavirus
Feb 10, 2020: Luminex reports fourth quarter and full-year 2019 results
Jan 12, 2020: Luminex Corporation announces 2019 highlights and 2020 guidance; company to present at 38th annual J.P. Morgan Healthcare conference
Nov 04, 2019: Luminex reports third quarter 2019 results and submission of VERIGENE II Gastrointestinal Flex Assay to the FDA
Nov 04, 2019: Luminex Corporation reports third quarter 2019 results and submission of VERIGENE II Gastrointestinal Flex Assay to the FDA
Jul 31, 2019: Luminex reports second quarter 2019 financial results and increase in quarterly dividend
May 06, 2019: Luminex reports first quarter 2019 financial results
Apr 17, 2019: BHP announces operational review for nine months ended March 31, 2019
Feb 04, 2019: Luminex reports fourth quarter and full-year 2018 financial results
Section 6 – Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

List of Tables
Luminex Corp, Key Facts
Luminex Corp, Key Employees
Luminex Corp, Key Employee Biographies
Luminex Corp, Major Products and Services
Luminex Corp, History
Luminex Corp, Other Locations
Luminex Corp, Subsidiaries
Luminex Corp, Key Competitors
Luminex Corp, Ratios based on current share price
Luminex Corp, Annual Ratios
Luminex Corp, Annual Ratios (Cont...1)
Luminex Corp, Annual Ratios (Cont...2)
Luminex Corp, Interim Ratios
Luminex Corp, Medical Equipment, Deals By Year, 2014 to YTD 2020
Luminex Corp, Medical Equipment, Deals By Type, 2014 to YTD 2020
Luminex Corp, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

List of Figures
Luminex Corp, Performance Chart (2015 - 2019)
Luminex Corp, Ratio Charts
Luminex Corp, Medical Equipment, Deals By Year, 2014 to YTD 2020
Luminex Corp, Medical Equipment, Deals by Type, 2014 to YTD 2020

★海外企業調査レポート[Luminex Corp (LMNX):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • EndoCeutics Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary EndoCeutics Inc (EndoCeutics) is a pharmaceutical company that develops hormone sensitive cancer prevention therapies for women’s health. The company's pipeline products include drugs for various indications such as endometriosis, male hypogonadism and antiandrogens, among others. It develop …
  • 4P-Pharma SAS:製薬・医療:M&Aディール及び事業提携情報
    Summary 4P-Pharma SAS (4P-Pharma) is a drug development company that offers drug pipeline for cancer and inflammatory diseases. The company’s pipeline product portfolio includes new chemical entities, biologics, added value generics and fixed dose combinations. Its pipeline candidates targets therap …
  • Huaneng Power International Inc:発電所・企業SWOT分析
    Huaneng Power International Inc - Power Plants and SWOT Analysis, 2017 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on k …
  • Ally Financial Inc.:企業の戦略・SWOT・財務情報
    Ally Financial Inc. - Strategy, SWOT and Corporate Finance Report Summary Ally Financial Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Peabody Energy Corp:企業の戦略・SWOT・財務分析
    Peabody Energy Corp - Strategy, SWOT and Corporate Finance Report Summary Peabody Energy Corp - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Octapharma AG:企業の戦略・SWOT・財務分析
    Octapharma AG - Strategy, SWOT and Corporate Finance Report Summary Octapharma AG - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • Hanwha Life Insurance Co Ltd:企業の戦略・SWOT・財務分析
    Hanwha Life Insurance Co Ltd - Strategy, SWOT and Corporate Finance Report Summary Hanwha Life Insurance Co Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • Luossavaara-Kiirunavaara AB:企業の戦略・SWOT・財務情報
    Luossavaara-Kiirunavaara AB - Strategy, SWOT and Corporate Finance Report Summary Luossavaara-Kiirunavaara AB - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • Actuant Corporation:企業の戦略・SWOT・財務情報
    Actuant Corporation - Strategy, SWOT and Corporate Finance Report Summary Actuant Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Hearst Corporation:企業のM&A・事業提携・投資動向
    Hearst Corporation - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Hearst Corporation Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), d …
  • LGT Bank Ltd.:企業の戦略・SWOT・財務分析
    LGT Bank Ltd. - Strategy, SWOT and Corporate Finance Report Summary LGT Bank Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • Hansen Medical Inc:医療機器:M&Aディール及び事業提携情報
    Summary Hansen Medical Inc (Hansen Medical), formerly Autocath Inc, a subsidiary of Auris Health Inc, is a medical device company that develops, manufactures and markets magellan robotic system for peripheral vascular intervention. The company’s products comprise robotic system, robotic catheters, s …
  • Globavir Biosciences Inc:医療機器:M&Aディール及び事業提携情報
    Summary Globavir Biosciences Inc (Globavir) is a biotechnology company that develop combination of drug therapies and diagnostic tests in the therapeutic areas of infection and immune-oncology. The company develops Globavir’s Drug Discovery Platform (GDDP), which generates small molecule candidates …
  • IES Holdings, Inc.:企業の戦略・SWOT・財務情報
    IES Holdings, Inc. - Strategy, SWOT and Corporate Finance Report Summary IES Holdings, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Engie Brasil Energia SA (EGIE3):電力:M&Aディール及び事業提携情報
    Summary Engie Brasil Energia SA (Engie Brasil), formerly Tractebel Energia SA, a subsidiary of Engie SA, undertakes the generation and commercialization of electricity. It generates energy through various source of energy such as hydro; thermal; and complementary energy sources including wind, solar …
  • Phoenix Global Resources Plc (PGR):企業の財務・戦略的SWOT分析
    Phoenix Global Resources Plc (PGR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and w …
  • University of Alberta-製薬・医療分野:企業M&A・提携分析
    Summary University of Alberta (UALBERTA) is an educational university that provides undergraduate, international, graduate, continuing studies and open studies programs. The university offers educational programs in agricultural food and nutritional science, English and film studies, history and cla …
  • Insperity Inc (NSP)
    Insperity Inc (NSP) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company
  • Rubicon Genomics Inc-製薬・医療分野:企業M&A・提携分析
    Summary Rubicon Genomics Inc (Rubicon Genomics), a subsidiary of the Takara Bio Group is a provider of pre-analytical amplification technologies. The company offers various types of kits for whole genome sequencing (WGS), whole exome sequencing (WES), targeted sequencing, copy number variation (CNV) …
  • Event Hospitality & Entertainment Ltd:企業の戦略・SWOT・財務情報
    Event Hospitality & Entertainment Ltd - Strategy, SWOT and Corporate Finance Report Summary Event Hospitality & Entertainment Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analy …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆